Free Newsletter

  Email address:
   

Site Search

Private Equity Firm Invests in CRO ChemPartner

publication date: Oct 26, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
ChemPartner, a CRO based in Shanghai, has reportedly accepted a capital investment of more than $30 million in return for a minority stake in the company. The investor is the American private equity firm TPG, a high-profile investment company that made its name and a considerable fortune in turnaround situations and leveraged buyouts. More details...

Stock Symbols: (NYSE: LLY) (NYSE: WX)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio Events

October 24, 2008
Beijing, China

>> More details...

Partner Events
 
October 11-13, 2008
Dalian, China
 
November 08, 2008
The Institute of Americas, UCSDa
 
November 9-11, 2008
Shanghai, China
 
February 23-25, 2009
San Diego

>> More details...

Partners